InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54
United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

35
Insider
Date
Role
Action
Shares
Price
Amount
Dale Muzzey
11 Sep 2024
Chief Scientific Officer
Sell
2,100
$26.17
$54.96K
Heinrich Dreismann
9 Sep 2024
Director
Sell
10,000
$27.05
$270.52K
Margaret Ancona
21 Aug 2024
SVP, Chief of Staff
Sell
11,538
$27.82
$320.99K
Paul J Diaz
15 May 2024
President and CEO
Sell
75,000
$25.07
$1.88M
Paul J Diaz
14 May 2024
President and CEO
Sell
95,000
$25.21
$2.39M
Lee Nisley Newcomer
13 May 2024
Director
Sell
6,200
$25.30
$156.86K
Paul J Diaz
13 May 2024
President and CEO
Sell
57,844
$25.13
$1.45M
Daniel K Spiegelman
2 Jun 2023
Director
Sell
8,638
$23.01
$198.76K
Nicole Lambert
27 Mar 2023
Chief Operating Officer
Sell
6,433
$23.48
$151.05K
Nicole Lambert
2 Mar 2023
Chief Operating Officer
Sell
13,184
$22.74
$299.82K
Richard Bryan Riggsbee
2 Mar 2023
Chief Financial Officer
Sell
15,000
$22.55
$338.25K
Richard Bryan Riggsbee
20 Jan 2023
Chief Financial Officer
Sell
9,400
$20.04
$188.39K
Richard Bryan Riggsbee
18 Jan 2023
Chief Financial Officer
Sell
600
$20.01
$12.01K
Richard Bryan Riggsbee
27 Dec 2022
Chief Financial Officer
Sell
20,000
$15.15
$302.99K
Daniel K Spiegelman
6 Jun 2022
Director
Sell
6,424
$19.25
$123.67K
Nicole Lambert
1 Oct 2021
See Remarks
Sell
1,420
$31.57
$44.83K
Nicole Lambert
27 Sep 2021
See Remarks
Sell
10,112
$33.10
$334.75K
Jerry S Lanchbury
23 Sep 2021
Chief Scientific Officer
Sell
200
$35.06
$7.01K
Nicole Lambert
27 Aug 2021
See Remarks
Sell
945
$34.50
$32.60K
Richard Bryan Riggsbee
3 Aug 2021
Chief Financial Officer
Sell
14,983
$35.14
$526.48K
Daniel K Spiegelman
17 Jun 2021
Director
Sell
3,139
$30.52
$95.79K
Daniel K Spiegelman
28 May 2021
Director
Sell
7,142
$28.99
$207.02K
Nicole Lambert
19 Apr 2021
See Remarks
Sell
5,890
$27.01
$159.09K
Nicole Lambert
19 Apr 2021
See Remarks
Sell
759
$27.01
$20.50K
Paul Parkinson
8 Jan 2021
EVP Strategy and Innovation
Sell
11,824
$25.00
$295.60K
Alexander Ford
15 Sep 2020
Chief Operating Officer
Sell
2,804
$13.78
$38.63K
Nicole Lambert
12 Feb 2020
President, MGL
Sell
4,354
$19.73
$85.91K
Alexander Ford
5 Feb 2020
President, MWH
Sell
7,273
$30.00
$218.19K
Richard Bryan Riggsbee
1 Aug 2019
Chief Financial Officer
Sell
25,000
$41.50
$1.04M
Bernard Tobin
1 Aug 2019
President Crescendo BioScience
Sell
11,712
$40.00
$468.48K
Ralph L McDade
12 Mar 2019
President Myriad RBM, Inc.
Sell
1,975
$31.00
$61.23K
Richard M Marsh
12 Jan 2018
E.V.P., General Counsel
Sell
13,759
$36.25
$498.76K
Walter Phd Gilbert
14 Dec 2017
Director
Sell
7,500
$33.19
$248.93K
Heinrich Dreismann
11 Dec 2017
Director
Sell
6,000
$33.50
$201.00K
Alexander Ford
13 Nov 2017
President, MGL
Sell
3,031
$31.64
$95.90K
Show all 135 transactions →

What was left out

Form 4 filings counted 546
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 78
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 15,234,074
Sales filed before the plan box existed 26
History held since 18 Oct 2006